SKWD (SKWD)

$1.9B
Market Cap
10.5
P/E Ratio
0.52
Beta
Dividend Yield
Piotroski 5/9Altman Z 0.8 DistressROIC−WACC -4.2%

Quantitative Summary

Deterministic

Financial health is average: Piotroski 5/9, Altman Z 0.8.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The capital allocation efficiency reveals a significant structural disconnect, as the return on invested capital of 3.7% falls substantially below the weighted average cost of capital at 7.9%, creating a negative spread that suggests value destruction despite robust top-line expansion. This fundamental weakness is underscored by an Altman Z-Score of 0.8, which flags elevated distress risk relative to historical norms, even though the Piotroski F-Score of 5/9 indicates moderate financial strength and operational resilience. The DuPont decomposition highlights a reliance on high profitability margins rather than asset turnover or leverage; specifically, net margins remain healthy at 12.0% while revenue surges by 23.7% year-over-year, yet this growth has not translated into improved capital efficiency or solvency metrics.

Valuation dynamics present an interesting tension between current market pricing and intrinsic value models derived from discounted cash flow analysis. The stock trades at a P/E multiple of 10.5x, which appears compressed relative to the implied growth trajectory embedded in the DCF fair value estimate of $515. While the low multiple might suggest a margin of safety for long-term holders if earnings persistently expand alongside revenue, it simultaneously reflects skepticism regarding future cash flow generation given the negative ROIC-WACC spread and weak balance sheet indicators. The market appears to be pricing in significant downside risks that current profitability metrics alone do not capture, particularly concerning the sustainability of growth without corresponding improvements in capital productivity.

The risk-reward profile is heavily skewed by the divergence between strong earnings momentum and deteriorating financial health markers. Although revenue growth remains aggressive at 23.7%, the combination of a distressed Z-Score and negative returns on invested capital introduces substantial uncertainty regarding the durability of these results. Investors must weigh whether current valuation levels adequately compensate for the potential volatility associated with low solvency ratios versus the upside if management can successfully pivot to generate positive spreads between returns and costs. The data suggests that any future appreciation hinges entirely on a fundamental inflection in operational efficiency rather than continued top-line acceleration alone.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →6%7.9%9.9%
2%$660$437$319
3%$859$515$357
4%$1257$632$408

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=7.9%, terminal growth 3%. Fair value $515 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

5/9
Piotroski F-Score
Average — mixed operational signals
0.8
Altman Z-Score
Distress Zone — below 1.8 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.

Profitability & Value Creation

12.0%
Net Margin
3.7%
ROIC
7.9%
WACC
ROIC − WACC Spread: -4.2%— Negative spread.
+23.7%
Revenue Growth (YoY)
+43.1%
Earnings Growth (YoY)
400.6M
Free Cash Flow

Balance Sheet Health

3.75x
Debt / Equity
28.3x
Interest Coverage
-0.2x
Net Debt / EBITDA
21.59%
FCF Yield
227.9M
EBITDA

Earnings Surprise History

Q4
✓ Beat
Est: $0.77
Act: $0.90
+16.8%
Q3
✓ Beat
Est: $0.87
Act: $0.89
+2.7%
Q2
✓ Beat
Est: $0.89
Act: $1.05
+18.6%
Q1
✓ Beat
Est: $1.02
Act: $1.17
+14.9%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

7.8
Forward P/E
PEG Ratio
1.72
Price/Book
515415
Avg Volume
$65.05
52W High
$40.60
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$10M
Tracked Passive Exposure
2
ETFs Holding SKWD
0.07%
Avg Weight in ETFs
$14B
Total ETF AUM

When investors buy or sell ETFs like KIE or VFH, the fund manager is mechanically forced to buy or sell SKWD shares regardless of SKWD's individual fundamentals. We estimate $10M of passive capital is structurally linked to SKWD through 2 tracked ETFs. Passive flows have a limited but growing influence on SKWD's daily trading dynamics.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 2 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in SKWD to visualize passive redemption contagion across ETFs and collateral stocks.

SKWD Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
SKWDEpicenterVFHETFKIEETFJPMHigh RiskBRK.BUnknownMALow RiskBACHigh RiskVLow Risk
SKWD Price Drop (%)0

If SKWD (SKWD) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies JPMorgan Chase & Co. (JPM) as the most exposed collateral stock, sharing 1 ETFs with SKWD. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 2 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

SKWD Ownership Dynamics

Ticker
SKWD

ETFs with Highest SKWD Exposure

Float lock-up computed from 2 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

SKWD Capital Efficiency

How efficiently does SKWD convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$401M
EBITDA
$228M
FCF Conversion
176%
Reinvestment Rate
-76%
176% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
3.7%
ROIC − WACC Spread
-4.2%

SKWD converts 176% of its EBITDA into free cash flow, an exceptional conversion rate indicating an asset-light business model with minimal capital reinvestment drag. However, the ROIC-WACC spread is negative (-4.2%), suggesting reinvested capital is destroying shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-04-06271$43.93$11,905.03
2026-04-026$43.07$258.42
2026-03-2735,394$43.26$1.5M
2026-03-2313$41.26$536.38
2026-03-1633$45.17$1,490.61
2026-03-04194$48.22$9,354.68
2026-03-02163,517$46.47$7.6M
2026-02-24119$47.16$5,612.04
2026-02-122,052$46.61$95,643.72
2026-02-0997$43.98$4,266.06
2026-01-0731$47.43$1,470.33
2025-12-297$51.85$362.95
2025-11-1743$48.70$2,094.1

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Compare SKWD to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.